TABLE 3.
LPV concentration (nanograms per milliliter) in MP, BM, and IP over 6 months postpartum
Values are presented as the median (IQR) of individual ratios, n (the number of samples available for analysis, of a possible 32 samples; missing samples due to shipping error), unless otherwise noted.
| Study Visit |
MPa |
BMb |
IPc |
BM/MP Ratio |
IP/MP Ratiod |
Relative Infant Dose |
|---|---|---|---|---|---|---|
| % | ||||||
| Month 1 | 1870 (586–4190) n = 4 | 530 (150–890) n = 6 | < LOQ n = 3 | 0.39 (0.07–0.62) | ||
| Month 3 | 10,900 (5495–15,750) n = 9 | 650 (160–940) n = 8 | < LOQ n = 9 | 0.056 (0.036–0.064) | ||
| Month 6 | 5790 (1230–10,600) n = 8 | 590 (200–770) n = 8 | < LOQ n = 8 | 0.088 (0.06–0.14) | 0.23 |
a
MP LPV was below the LOQ in one sample in months 1 and 6.
b
BM LPV was below the LOQ in one sample in months 1 and 3, and in two samples in month 6.
c
IP LPV was below the LOQ in three, eight, and seven samples in months 1, 3, and 6, respectively.
d
LPV concentration fell below the LOQ for all IP samples; therefore, the IP/MP ratio was not calculated.